Tempest Therapeutics IncNASDAQ:TPST
- LAST PRICE1.7000
- TODAY'S CHANGE (%)-0.0200 (-1.1628%)
- Bid / Lots1.6500/ 10
- Ask / Lots1.7100/ 15
- Open / Previous Close1.7200 / 1.7200
- Day Range
- 52 Week Range
- Volume421,655
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TPST |
|---|---|---|
| 09:32 ET | 10606 | 1.67 |
| 09:34 ET | 1206 | 1.68 |
| 09:36 ET | 1600 | 1.69 |
| 09:38 ET | 2300 | 1.71 |
| 09:39 ET | 468 | 1.7292 |
| 09:41 ET | 150 | 1.72 |
| 09:43 ET | 183 | 1.7191 |
| 09:45 ET | 8302 | 1.7 |
| 09:48 ET | 1780 | 1.71 |
| 09:50 ET | 421 | 1.715 |
| 09:52 ET | 2240 | 1.715 |
| 09:56 ET | 547 | 1.71 |
| 09:57 ET | 837 | 1.7106 |
| 09:59 ET | 100 | 1.71 |
| 10:08 ET | 100 | 1.705 |
| 10:10 ET | 7195 | 1.6915 |
| 10:12 ET | 200 | 1.695 |
| 10:14 ET | 1500 | 1.68 |
| 10:15 ET | 329 | 1.6899 |
| 10:17 ET | 800 | 1.685 |
| 10:19 ET | 1368 | 1.67 |
| 10:21 ET | 1358 | 1.6798 |
| 10:24 ET | 854 | 1.6794 |
| 10:26 ET | 400 | 1.6701 |
| 10:30 ET | 100 | 1.6746 |
| 10:32 ET | 7462 | 1.6601 |
| 10:33 ET | 1070 | 1.66 |
| 10:35 ET | 100 | 1.665 |
| 10:37 ET | 16193 | 1.65 |
| 10:39 ET | 2503 | 1.655 |
| 10:42 ET | 5443 | 1.6675 |
| 10:44 ET | 1390 | 1.665 |
| 10:46 ET | 200 | 1.665 |
| 10:48 ET | 708 | 1.66 |
| 10:50 ET | 3558 | 1.66 |
| 10:51 ET | 817 | 1.655 |
| 10:55 ET | 8000 | 1.6599 |
| 10:57 ET | 547 | 1.655 |
| 11:00 ET | 6237 | 1.665 |
| 11:02 ET | 200 | 1.665 |
| 11:04 ET | 600 | 1.665 |
| 11:06 ET | 906 | 1.668 |
| 11:08 ET | 300 | 1.67 |
| 11:09 ET | 140 | 1.67 |
| 11:11 ET | 600 | 1.665 |
| 11:15 ET | 300 | 1.66 |
| 11:18 ET | 850 | 1.6594 |
| 11:20 ET | 500 | 1.665 |
| 11:26 ET | 6893 | 1.67 |
| 11:27 ET | 100 | 1.675 |
| 11:29 ET | 1200 | 1.675 |
| 11:40 ET | 1400 | 1.68 |
| 11:42 ET | 100 | 1.68 |
| 11:44 ET | 1009 | 1.68 |
| 11:45 ET | 1100 | 1.67 |
| 11:47 ET | 200 | 1.675 |
| 11:56 ET | 7624 | 1.66 |
| 11:58 ET | 1500 | 1.67 |
| 12:00 ET | 1890 | 1.67 |
| 12:02 ET | 696 | 1.675 |
| 12:03 ET | 100 | 1.675 |
| 12:05 ET | 2200 | 1.6701 |
| 12:07 ET | 9680 | 1.67 |
| 12:09 ET | 500 | 1.675 |
| 12:14 ET | 348 | 1.675 |
| 12:16 ET | 695 | 1.6788 |
| 12:21 ET | 4782 | 1.6797 |
| 12:25 ET | 2000 | 1.68 |
| 12:30 ET | 500 | 1.67 |
| 12:34 ET | 399 | 1.675 |
| 12:36 ET | 150 | 1.67 |
| 12:41 ET | 1326 | 1.68 |
| 12:43 ET | 750 | 1.6769 |
| 12:45 ET | 296 | 1.67 |
| 12:50 ET | 2079 | 1.68 |
| 12:52 ET | 711 | 1.67 |
| 12:57 ET | 100 | 1.675 |
| 12:59 ET | 4660 | 1.67 |
| 01:03 ET | 100 | 1.67 |
| 01:06 ET | 10840 | 1.675 |
| 01:08 ET | 3026 | 1.67 |
| 01:10 ET | 181 | 1.6699 |
| 01:12 ET | 300 | 1.665 |
| 01:15 ET | 200 | 1.6627 |
| 01:21 ET | 120 | 1.66 |
| 01:24 ET | 5868 | 1.675 |
| 01:26 ET | 15115 | 1.67 |
| 01:28 ET | 200 | 1.6794 |
| 01:30 ET | 319 | 1.68 |
| 01:32 ET | 8185 | 1.67 |
| 01:35 ET | 1642 | 1.6699 |
| 01:39 ET | 1547 | 1.6699 |
| 01:44 ET | 100 | 1.67 |
| 01:48 ET | 2300 | 1.67 |
| 01:50 ET | 289 | 1.6799 |
| 01:51 ET | 250 | 1.675 |
| 01:53 ET | 178 | 1.6794 |
| 01:55 ET | 400 | 1.675 |
| 02:00 ET | 599 | 1.675 |
| 02:02 ET | 185 | 1.675 |
| 02:09 ET | 328 | 1.6794 |
| 02:13 ET | 900 | 1.675 |
| 02:15 ET | 100 | 1.675 |
| 02:18 ET | 1126 | 1.6703 |
| 02:20 ET | 5796 | 1.67 |
| 02:22 ET | 115 | 1.6694 |
| 02:26 ET | 3954 | 1.6601 |
| 02:27 ET | 8678 | 1.6603 |
| 02:29 ET | 4234 | 1.665 |
| 02:31 ET | 336 | 1.665 |
| 02:40 ET | 6289 | 1.665 |
| 02:42 ET | 200 | 1.665 |
| 02:44 ET | 184 | 1.665 |
| 02:45 ET | 835 | 1.67 |
| 02:47 ET | 100 | 1.665 |
| 02:51 ET | 900 | 1.6652 |
| 02:56 ET | 199 | 1.665 |
| 03:05 ET | 9622 | 1.67 |
| 03:12 ET | 100 | 1.665 |
| 03:14 ET | 129 | 1.66 |
| 03:16 ET | 100 | 1.665 |
| 03:18 ET | 500 | 1.665 |
| 03:20 ET | 1000 | 1.665 |
| 03:21 ET | 200 | 1.665 |
| 03:23 ET | 1302 | 1.6699 |
| 03:25 ET | 4091 | 1.675 |
| 03:27 ET | 600 | 1.675 |
| 03:30 ET | 1000 | 1.675 |
| 03:32 ET | 4876 | 1.675 |
| 03:34 ET | 4241 | 1.68 |
| 03:36 ET | 1450 | 1.67 |
| 03:38 ET | 1896 | 1.675 |
| 03:39 ET | 5576 | 1.685 |
| 03:41 ET | 4843 | 1.685 |
| 03:43 ET | 5896 | 1.68 |
| 03:45 ET | 1721 | 1.695 |
| 03:48 ET | 500 | 1.695 |
| 03:50 ET | 16895 | 1.7099 |
| 03:52 ET | 1000 | 1.705 |
| 03:54 ET | 7702 | 1.695 |
| 03:56 ET | 24003 | 1.7 |
| 03:57 ET | 500 | 1.705 |
| 03:59 ET | 5904 | 1.7 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tempest Therapeutics Inc | 38.2M | -1.0x | --- |
ProMIS Neurosciences Inc | 38.3M | -1.9x | --- |
Reviva Pharmaceuticals Holdings, Inc. | 37.6M | -0.8x | --- |
Ocean Biomedical Inc | 38.8M | -0.4x | --- |
Mink Therapeutics Inc | 36.6M | -1.5x | --- |
Immuneering Corp | 36.5M | -0.7x | --- |
Company Information
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a range of tumors. Its two clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPAR). The ongoing global randomized Phase Ib/II trial of TPST-1120 combined with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). The Company’s second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, is in an ongoing Phase I combination trial in patients with endometrial cancer.
Contact Information
- Headquarters
- 2000 SIERRA POINT PARKWAY, SUITE 400BRISBANE, CA, United States 94005
- Phone
- 415-798-8589
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Michael Raab
- President, Chief Executive Officer, Director
- Stephen Brady
- Executive Vice President, Chief Medical Officer
- Samuel Whiting
- Vice President - Strategy and Finance, Corporate Secretary
- Nicholas Maestas
- Independent Director
- Geoffrey Nichol
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $38.2M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 22.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.65 |
EPS | $-1.76 |
Book Value | $1.21 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
